SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-020115
Filing Date
2023-11-02
Accepted
2023-11-02 20:51:59
Documents
2
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3368
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4686
  Complete submission text file 0000899243-23-020115.txt   9431
Mailing Address FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Musso Alan A (Reporting) CIK: 0001295830 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 231374208

Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations